Literature DB >> 16574794

Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake.

Kirsty L Smith1, Michael Patterson, Waljit S Dhillo, Sejal R Patel, Nina M Semjonous, James V Gardiner, Mohammad A Ghatei, Stephen R Bloom.   

Abstract

Neuropeptide S (NPS) is a recently discovered peptide shown to be involved in the modulation of arousal and fear responses. It has also been shown that lateral ventricle administration of NPS causes a significant decrease in food intake. Neuropeptides involved in the modulation of arousal have been shown to be involved in the regulation of the hypothalamo-pituitary adrenal (HPA) axis and food intake. In this study, we have examined the effect of intracerebroventricular (ICV) administration of NPS on behavior, regulation of the HPA axis, and food intake. ICV NPS significantly increased plasma ACTH and corticosterone 10 and 40 min after injection, respectively. A single ICV injection of NPS caused a significant increase in rearing activity as well as ambulatory movement for up to 45 min after injection. We then studied the effect of paraventricular nucleus (PVN) administration of NPS on the regulation of the HPA axis, behavior, and food intake. There was a significant increase in plasma ACTH and corticosterone after a single NPS PVN injection. Incubation of hypothalamic explants with increasing concentrations of NPS caused a significant increase in CRH and arginine vasopressin release. In addition, PVN administration of NPS dose-dependently inhibited food intake in the first hour after injection, although no effect on food intake was seen after this time. PVN administration of NPS caused a significant increase in rearing activity. These data demonstrate a novel role for NPS in the stimulation of the HPA axis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574794     DOI: 10.1210/en.2005-1280

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  55 in total

1.  Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.

Authors:  Yuan Liao; Bin Lu; Qiang Ma; Gang Wu; Xiangru Lai; Jiashu Zang; Ying Shi; Dongxiang Liu; Feng Han; Naiming Zhou
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

2.  Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons.

Authors:  Irina A Ionescu; Julien Dine; Yi-Chun Yen; Dominik R Buell; Leonie Herrmann; Florian Holsboer; Matthias Eder; Rainer Landgraf; Ulrike Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

3.  Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1.

Authors:  Hongyan Zhu; Melissa K Mingler; Melissa L McBride; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Michael T Williams; Charles V Vorhees; Marc E Rothenberg
Journal:  Psychoneuroendocrinology       Date:  2010-02-19       Impact factor: 4.905

4.  Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system.

Authors:  Marsida Kallupi; Nazzareno Cannella; Daina Economidou; Massimo Ubaldi; Barbara Ruggeri; Friedbert Weiss; Maurizio Massi; Juan Marugan; Markus Heilig; Patricia Bonnavion; Luis de Lecea; Roberto Ciccocioppo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

5.  The temporal sequence of gut peptide CNS interactions tracked in vivo by magnetic resonance imaging.

Authors:  Yu-Ting Kuo; James R C Parkinson; Owais B Chaudhri; Amy H Herlihy; Po-Wah So; Waljit S Dhillo; Caroline J Small; Stephen R Bloom; Jimmy D Bell
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

6.  Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor.

Authors:  Naoe Okamura; Stephen A Habay; Joanne Zeng; A Richard Chamberlin; Rainer K Reinscheid
Journal:  J Pharmacol Exp Ther       Date:  2008-03-12       Impact factor: 4.030

7.  Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor.

Authors:  Kay Jüngling; Xiaobin Liu; Jörg Lesting; Philippe Coulon; L Sosulina; Rainer K Reinscheid; Hans-Christian Pape
Journal:  J Physiol       Date:  2012-05-08       Impact factor: 5.182

8.  Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice.

Authors:  Carina R Boeck; Caroline Martinello; Adalberto A de Castro; Morgana Moretti; Tiago Dos Santos Casagrande; Remo Guerrini; Girolamo Calo'; Elaine C Gavioli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-19       Impact factor: 3.000

9.  Neonatal overfeeding alters adult anxiety and stress responsiveness.

Authors:  Sarah J Spencer; Alan Tilbrook
Journal:  Psychoneuroendocrinology       Date:  2009-03-20       Impact factor: 4.905

10.  Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance.

Authors:  N M Semjonous; K L Smith; J R C Parkinson; D J L Gunner; Y-L Liu; K G Murphy; M A Ghatei; S R Bloom; C J Small
Journal:  Int J Obes (Lond)       Date:  2009-06-02       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.